OptimizeRx Corporation (OPRX)
9.01
0.38 (4.40%)
At close: Mar 24, 2025, 3:59 PM
8.88
-1.49%
After-hours: Mar 24, 2025, 07:47 PM EDT
4.40% (1D)
| Bid | 8.89 |
| Market Cap | 166.6M |
| Revenue (ttm) | 92.14M |
| Net Income (ttm) | -15.54M |
| EPS (ttm) | -1.1 |
| PE Ratio (ttm) | -8.19 |
| Forward PE | 16 |
| Analyst | Buy |
| Ask | 9.21 |
| Volume | 179,336 |
| Avg. Volume (20D) | 520,977 |
| Open | 8.76 |
| Previous Close | 8.63 |
| Day's Range | 8.51 - 9.04 |
| 52-Week Range | 3.78 - 14.13 |
| Beta | 1.31 |
About OPRX
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support mes...
Sector Healthcare
IPO Date Nov 28, 2007
Employees 128
Stock Exchange NASDAQ
Ticker Symbol OPRX
Website https://www.optimizerx.com
Analyst Forecast
According to 8 analyst ratings, the average rating for OPRX stock is "Buy." The 12-month stock price forecast is $8, which is a decrease of -11.21% from the latest price.
Stock ForecastsNext Earnings Release
OptimizeRx Corporation is scheduled to release its earnings on May 13, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+51.69%
OptimizeRx shares are trading higher after the com...
Unlock content with
Pro Subscription
2 months ago
-7.04%
OptimizeRx shares are trading lower after RBC Capital downgraded the stock from Outperform to Sector Perform and cut its price target from $7 to $6.
